Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04531397 |
|
Recruitment Status :
Withdrawn
(lack of funding)
First Posted : August 28, 2020
Last Update Posted : December 29, 2020
|
Sponsor:
Children's Hospital of Fudan University
Information provided by (Responsible Party):
Children's Hospital of Fudan University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Estimated Primary Completion Date : | June 1, 2022 |
| Estimated Study Completion Date : | December 31, 2022 |